The Green Organic Dutchman (TGOD) and HelloMD Partner to Streamline Medical Cannabis Patient Experience
December 13 2018 - 7:30AM
The Green Organic Dutchman Holdings Ltd. (the
"
Company" or "
TGOD")
(TSX:TGOD) (US:TGODF) and HelloMD, a leading
online cannabis healthcare company, are pleased to announce a
partnership to streamline TGOD’s medical cannabis onboarding
experience.
TGOD will begin selling its premium,
certified-organic cannabis to medical patients in late January
2019. The integration of HelloMD's convenient online clinic
services will enhance TGOD’s best-in-class approach to patient
care.
HelloMD provides a solution for patients looking
to conveniently access medical cannabis in Canada online. By
leveraging HelloMD’s white-label patient services platform, TGOD
will ensure patients have convenient access to independent,
practitioner-led advice and education about medical cannabis.
Prospective patients can connect online with a licensed
practitioner seven days a week from the comfort of their preferred
location. Patients who obtain appropriate documentation can
purchase from TGOD’s broad range of premium medical cannabis
products.
“At TGOD, “Making Life Better” is not just our
brand tagline, it’s our ongoing commitment to every consumer,” said
Andrew Pollock, Vice President of Marketing at TGOD. “Patients
deserve premium organic cannabis and through the partnership with
HelloMD, we are pleased to provide increased access to TGOD’s
product lines with the highest level of customer service and
functionality to our patients.”
“The journey from canna-curious, to feeling
better, can be complex for Canadians considering medical cannabis,”
said Larry Lisser, SVP of Business Development at HelloMD.
“HelloMD’s services enable our partners to improve their patients’
experience by streamlining the onboarding process. In this joint
effort with TGOD, we will ensure patients receive the best
personalized advice on organic medical cannabis to move
forward.”
To become a TGOD patient, click here.
For Media Inquiries:
HelloMD: Garrett Repski, Project Manager, Marigold Marketing
& PR, 1-647-972-2466, garrett@marigoldpr.com TGOD: Andrew
Pollock, Vice President, Marketing, 905-304-4201,
apollock@tgod.ca
About HelloMD: HelloMD has facilitated more
than 100,000 virtual consults between medical cannabis patients and
licensed practitioners. The company’s white-label solutions enable
third parties to quickly deploy a turnkey telehealth solution,
complete with the technology, practitioners and support personnel
required to improve their own patient onboarding processes. For
further information about HelloMD:Email: partners@hellomd.comVisit:
https://www.hellomd.com
ABOUT THE GREEN ORGANIC DUTCHMAN HOLDINGS
LTDThe Green Organic Dutchman Holdings Ltd. is a research
& development company licensed under the Access to
Cannabis for Medical Purposes Regulations (“ACMPR”) to
cultivate medical cannabis. The Company carries out its principal
activities producing cannabis from its facilities in Ancaster,
Ont., pursuant to the provisions of the ACMPR and
the Controlled Drugs and Substances Act (Canada) and its
regulations.
The Company grows high quality,
organic cannabis with sustainable, all-natural principles.
TGOD's products are laboratory tested to ensure patients have
access to a standardized, safe and consistent product. TGOD
has a funded capacity of 170,000 kg of cultivation facilities in
Ontario and Quebec and Jamaica.
TGOD’s Common Shares and warrants issued under
the indenture dated November 1, 2017 trade on the TSX under the
symbol "TGOD" and “TGOD.WT”, respectively.
CONTACT INFORMATIONInvestor
RelationsEmail:invest@tgod.ca Phone: 1 (416) 900-7621www.tgod.ca
Forward-Looking Information Cautionary
Statement
This news release includes statements containing
certain "forward-looking information" within the meaning of
applicable securities law ("forward-looking statements"). Forward
looking statements in this release includes, but is not limited to,
statements about the future legalization of recreational cannabis
and cannabis-infused products in Canada, statements about future
research, development and innovation by the Company, statements
about the offering of any particular products by the Company in any
particular territory and statements regarding the future
performance of the Company. Forward-looking statements are
frequently characterized by words such as "plan", "continue",
"expect", "project", "intend", "believe", "anticipate", "estimate",
"may", "will", "potential", "proposed" and other similar words, or
statements that certain events or conditions "may" or "will" occur.
These statements are only predictions. Various assumptions were
used in drawing the conclusions or making the projections contained
in the forward-looking statements throughout this news release.
Forward-looking statements are based on the opinions and estimates
of management at the date the statements are made, and are subject
to a variety of risks and uncertainties and other factors that
could cause actual events or results to differ materially from
those projected in the forward-looking statements. The Company is
under no obligation, and expressly disclaims any intention or
obligation, to update or revise any forward-looking statements,
whether as a result of new information, future events or otherwise,
except as expressly required by applicable law.
Neither TSX nor its Regulation Services Provider
(as that term is defined in the policies of Toronto Stock Exchange)
accept responsibility for the adequacy or accuracy of this
release.